nodes	percent_of_prediction	percent_of_DWPC	metapath
Zolpidem—CYP3A7-CYP3A51P—Tamoxifen—pancreatic cancer	0.0499	0.0691	CbGbCtD
Zolpidem—CYP3A7—Tamoxifen—pancreatic cancer	0.0499	0.0691	CbGbCtD
Zolpidem—CYP3A7—Irinotecan—pancreatic cancer	0.0383	0.0531	CbGbCtD
Zolpidem—CYP3A7-CYP3A51P—Irinotecan—pancreatic cancer	0.0383	0.0531	CbGbCtD
Zolpidem—CYP3A5—Tamoxifen—pancreatic cancer	0.0374	0.0518	CbGbCtD
Zolpidem—CYP1A2—Dacarbazine—pancreatic cancer	0.035	0.0485	CbGbCtD
Zolpidem—CYP3A5—Erlotinib—pancreatic cancer	0.0318	0.0441	CbGbCtD
Zolpidem—CYP2C19—Tamoxifen—pancreatic cancer	0.0302	0.0418	CbGbCtD
Zolpidem—CYP3A5—Irinotecan—pancreatic cancer	0.0287	0.0398	CbGbCtD
Zolpidem—CYP3A7-CYP3A51P—Docetaxel—pancreatic cancer	0.0281	0.0389	CbGbCtD
Zolpidem—CYP3A7—Docetaxel—pancreatic cancer	0.0281	0.0389	CbGbCtD
Zolpidem—CYP3A7—Sunitinib—pancreatic cancer	0.0279	0.0387	CbGbCtD
Zolpidem—CYP3A7-CYP3A51P—Sunitinib—pancreatic cancer	0.0279	0.0387	CbGbCtD
Zolpidem—CYP1A2—Tamoxifen—pancreatic cancer	0.0279	0.0386	CbGbCtD
Zolpidem—CYP2C9—Tamoxifen—pancreatic cancer	0.0251	0.0348	CbGbCtD
Zolpidem—CYP1A2—Erlotinib—pancreatic cancer	0.0237	0.0328	CbGbCtD
Zolpidem—CYP2D6—Tamoxifen—pancreatic cancer	0.023	0.0318	CbGbCtD
Zolpidem—CYP3A5—Docetaxel—pancreatic cancer	0.0211	0.0292	CbGbCtD
Zolpidem—CYP3A5—Sunitinib—pancreatic cancer	0.021	0.029	CbGbCtD
Zolpidem—CYP1A2—Fluorouracil—pancreatic cancer	0.0205	0.0284	CbGbCtD
Zolpidem—CYP2D6—Erlotinib—pancreatic cancer	0.0195	0.027	CbGbCtD
Zolpidem—CYP2C9—Fluorouracil—pancreatic cancer	0.0185	0.0256	CbGbCtD
Zolpidem—CYP3A4—Tamoxifen—pancreatic cancer	0.0146	0.0202	CbGbCtD
Zolpidem—CYP3A4—Erlotinib—pancreatic cancer	0.0124	0.0172	CbGbCtD
Zolpidem—CYP3A4—Irinotecan—pancreatic cancer	0.0112	0.0155	CbGbCtD
Zolpidem—CYP2D6—Doxorubicin—pancreatic cancer	0.00963	0.0133	CbGbCtD
Zolpidem—CYP3A4—Docetaxel—pancreatic cancer	0.00821	0.0114	CbGbCtD
Zolpidem—CYP3A4—Sunitinib—pancreatic cancer	0.00818	0.0113	CbGbCtD
Zolpidem—CYP3A4—Doxorubicin—pancreatic cancer	0.00612	0.00848	CbGbCtD
Zolpidem—Tolmetin—CXCL8—pancreatic cancer	0.00465	0.774	CrCbGaD
Zolpidem—Tolmetin—PTGS2—pancreatic cancer	0.00136	0.226	CrCbGaD
Zolpidem—Infestation—Epirubicin—pancreatic cancer	0.000143	0.000524	CcSEcCtD
Zolpidem—Infestation NOS—Epirubicin—pancreatic cancer	0.000143	0.000524	CcSEcCtD
Zolpidem—Drowsiness—Epirubicin—pancreatic cancer	0.000143	0.000524	CcSEcCtD
Zolpidem—Bronchitis—Doxorubicin—pancreatic cancer	0.000142	0.000523	CcSEcCtD
Zolpidem—Arthralgia—Docetaxel—pancreatic cancer	0.000141	0.000517	CcSEcCtD
Zolpidem—Myalgia—Docetaxel—pancreatic cancer	0.000141	0.000517	CcSEcCtD
Zolpidem—Chest pain—Docetaxel—pancreatic cancer	0.000141	0.000517	CcSEcCtD
Zolpidem—Nausea—Sunitinib—pancreatic cancer	0.000141	0.000517	CcSEcCtD
Zolpidem—Asthenia—Irinotecan—pancreatic cancer	0.00014	0.000515	CcSEcCtD
Zolpidem—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.00014	0.000514	CcSEcCtD
Zolpidem—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.00014	0.000514	CcSEcCtD
Zolpidem—Stomatitis—Epirubicin—pancreatic cancer	0.000139	0.000511	CcSEcCtD
Zolpidem—Urinary tract infection—Epirubicin—pancreatic cancer	0.000139	0.00051	CcSEcCtD
Zolpidem—Conjunctivitis—Epirubicin—pancreatic cancer	0.000139	0.00051	CcSEcCtD
Zolpidem—Dysuria—Doxorubicin—pancreatic cancer	0.000138	0.000509	CcSEcCtD
Zolpidem—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000138	0.000506	CcSEcCtD
Zolpidem—Dry mouth—Docetaxel—pancreatic cancer	0.000138	0.000506	CcSEcCtD
Zolpidem—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.000137	0.000506	CcSEcCtD
Zolpidem—Pollakiuria—Doxorubicin—pancreatic cancer	0.000137	0.000503	CcSEcCtD
Zolpidem—Asthenia—Gemcitabine—pancreatic cancer	0.000136	0.000501	CcSEcCtD
Zolpidem—Confusional state—Docetaxel—pancreatic cancer	0.000136	0.0005	CcSEcCtD
Zolpidem—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.000135	0.000497	CcSEcCtD
Zolpidem—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000135	0.000496	CcSEcCtD
Zolpidem—Oedema—Docetaxel—pancreatic cancer	0.000135	0.000496	CcSEcCtD
Zolpidem—Epistaxis—Epirubicin—pancreatic cancer	0.000134	0.000495	CcSEcCtD
Zolpidem—Pruritus—Gemcitabine—pancreatic cancer	0.000134	0.000494	CcSEcCtD
Zolpidem—Infection—Docetaxel—pancreatic cancer	0.000134	0.000493	CcSEcCtD
Zolpidem—Weight decreased—Doxorubicin—pancreatic cancer	0.000134	0.000492	CcSEcCtD
Zolpidem—Sinusitis—Epirubicin—pancreatic cancer	0.000134	0.000492	CcSEcCtD
Zolpidem—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000133	0.000491	CcSEcCtD
Zolpidem—Diarrhoea—Irinotecan—pancreatic cancer	0.000133	0.000491	CcSEcCtD
Zolpidem—Pneumonia—Doxorubicin—pancreatic cancer	0.000133	0.000488	CcSEcCtD
Zolpidem—Shock—Docetaxel—pancreatic cancer	0.000133	0.000488	CcSEcCtD
Zolpidem—Nervous system disorder—Docetaxel—pancreatic cancer	0.000132	0.000486	CcSEcCtD
Zolpidem—Pruritus—Fluorouracil—pancreatic cancer	0.000132	0.000486	CcSEcCtD
Zolpidem—Infestation—Doxorubicin—pancreatic cancer	0.000132	0.000485	CcSEcCtD
Zolpidem—Infestation NOS—Doxorubicin—pancreatic cancer	0.000132	0.000485	CcSEcCtD
Zolpidem—Drowsiness—Doxorubicin—pancreatic cancer	0.000132	0.000485	CcSEcCtD
Zolpidem—Tachycardia—Docetaxel—pancreatic cancer	0.000132	0.000484	CcSEcCtD
Zolpidem—Skin disorder—Docetaxel—pancreatic cancer	0.000131	0.000482	CcSEcCtD
Zolpidem—Diarrhoea—Gemcitabine—pancreatic cancer	0.00013	0.000478	CcSEcCtD
Zolpidem—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000129	0.000476	CcSEcCtD
Zolpidem—Dizziness—Irinotecan—pancreatic cancer	0.000129	0.000474	CcSEcCtD
Zolpidem—Stomatitis—Doxorubicin—pancreatic cancer	0.000129	0.000473	CcSEcCtD
Zolpidem—Anorexia—Docetaxel—pancreatic cancer	0.000128	0.000473	CcSEcCtD
Zolpidem—Rhinitis—Epirubicin—pancreatic cancer	0.000128	0.000472	CcSEcCtD
Zolpidem—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000128	0.000472	CcSEcCtD
Zolpidem—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000128	0.000472	CcSEcCtD
Zolpidem—Diarrhoea—Fluorouracil—pancreatic cancer	0.000128	0.00047	CcSEcCtD
Zolpidem—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000127	0.000468	CcSEcCtD
Zolpidem—Pharyngitis—Epirubicin—pancreatic cancer	0.000127	0.000467	CcSEcCtD
Zolpidem—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000126	0.000465	CcSEcCtD
Zolpidem—Hypotension—Docetaxel—pancreatic cancer	0.000126	0.000463	CcSEcCtD
Zolpidem—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000126	0.000463	CcSEcCtD
Zolpidem—Urethral disorder—Epirubicin—pancreatic cancer	0.000125	0.000461	CcSEcCtD
Zolpidem—Epistaxis—Doxorubicin—pancreatic cancer	0.000124	0.000458	CcSEcCtD
Zolpidem—Vomiting—Irinotecan—pancreatic cancer	0.000124	0.000456	CcSEcCtD
Zolpidem—Sinusitis—Doxorubicin—pancreatic cancer	0.000124	0.000455	CcSEcCtD
Zolpidem—Dizziness—Fluorouracil—pancreatic cancer	0.000123	0.000454	CcSEcCtD
Zolpidem—Visual impairment—Epirubicin—pancreatic cancer	0.000123	0.000454	CcSEcCtD
Zolpidem—Rash—Irinotecan—pancreatic cancer	0.000123	0.000452	CcSEcCtD
Zolpidem—Dermatitis—Irinotecan—pancreatic cancer	0.000123	0.000452	CcSEcCtD
Zolpidem—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000123	0.000452	CcSEcCtD
Zolpidem—Headache—Irinotecan—pancreatic cancer	0.000122	0.000449	CcSEcCtD
Zolpidem—Insomnia—Docetaxel—pancreatic cancer	0.000122	0.000448	CcSEcCtD
Zolpidem—Paraesthesia—Docetaxel—pancreatic cancer	0.000121	0.000445	CcSEcCtD
Zolpidem—Vomiting—Gemcitabine—pancreatic cancer	0.000121	0.000444	CcSEcCtD
Zolpidem—Dyspnoea—Docetaxel—pancreatic cancer	0.00012	0.000442	CcSEcCtD
Zolpidem—Somnolence—Docetaxel—pancreatic cancer	0.00012	0.000441	CcSEcCtD
Zolpidem—Rash—Gemcitabine—pancreatic cancer	0.00012	0.000441	CcSEcCtD
Zolpidem—Dermatitis—Gemcitabine—pancreatic cancer	0.00012	0.00044	CcSEcCtD
Zolpidem—Eye disorder—Epirubicin—pancreatic cancer	0.00012	0.00044	CcSEcCtD
Zolpidem—Tinnitus—Epirubicin—pancreatic cancer	0.000119	0.000439	CcSEcCtD
Zolpidem—Headache—Gemcitabine—pancreatic cancer	0.000119	0.000438	CcSEcCtD
Zolpidem—Cardiac disorder—Epirubicin—pancreatic cancer	0.000119	0.000437	CcSEcCtD
Zolpidem—Flushing—Epirubicin—pancreatic cancer	0.000119	0.000437	CcSEcCtD
Zolpidem—Vomiting—Fluorouracil—pancreatic cancer	0.000119	0.000437	CcSEcCtD
Zolpidem—Rhinitis—Doxorubicin—pancreatic cancer	0.000119	0.000437	CcSEcCtD
Zolpidem—Dyspepsia—Docetaxel—pancreatic cancer	0.000119	0.000436	CcSEcCtD
Zolpidem—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000118	0.000433	CcSEcCtD
Zolpidem—Rash—Fluorouracil—pancreatic cancer	0.000118	0.000433	CcSEcCtD
Zolpidem—Dermatitis—Fluorouracil—pancreatic cancer	0.000118	0.000433	CcSEcCtD
Zolpidem—Pharyngitis—Doxorubicin—pancreatic cancer	0.000118	0.000432	CcSEcCtD
Zolpidem—Decreased appetite—Docetaxel—pancreatic cancer	0.000117	0.000431	CcSEcCtD
Zolpidem—Headache—Fluorouracil—pancreatic cancer	0.000117	0.00043	CcSEcCtD
Zolpidem—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000117	0.00043	CcSEcCtD
Zolpidem—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000116	0.000428	CcSEcCtD
Zolpidem—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000116	0.000428	CcSEcCtD
Zolpidem—Fatigue—Docetaxel—pancreatic cancer	0.000116	0.000427	CcSEcCtD
Zolpidem—Urethral disorder—Doxorubicin—pancreatic cancer	0.000116	0.000427	CcSEcCtD
Zolpidem—Nausea—Irinotecan—pancreatic cancer	0.000116	0.000426	CcSEcCtD
Zolpidem—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000115	0.000424	CcSEcCtD
Zolpidem—Constipation—Docetaxel—pancreatic cancer	0.000115	0.000424	CcSEcCtD
Zolpidem—Pain—Docetaxel—pancreatic cancer	0.000115	0.000424	CcSEcCtD
Zolpidem—Chills—Epirubicin—pancreatic cancer	0.000115	0.000422	CcSEcCtD
Zolpidem—Arrhythmia—Epirubicin—pancreatic cancer	0.000114	0.00042	CcSEcCtD
Zolpidem—Visual impairment—Doxorubicin—pancreatic cancer	0.000114	0.00042	CcSEcCtD
Zolpidem—Nausea—Gemcitabine—pancreatic cancer	0.000113	0.000415	CcSEcCtD
Zolpidem—Mental disorder—Epirubicin—pancreatic cancer	0.000112	0.000412	CcSEcCtD
Zolpidem—Malnutrition—Epirubicin—pancreatic cancer	0.000111	0.00041	CcSEcCtD
Zolpidem—Erythema—Epirubicin—pancreatic cancer	0.000111	0.00041	CcSEcCtD
Zolpidem—Feeling abnormal—Docetaxel—pancreatic cancer	0.000111	0.000409	CcSEcCtD
Zolpidem—Nausea—Fluorouracil—pancreatic cancer	0.000111	0.000408	CcSEcCtD
Zolpidem—Eye disorder—Doxorubicin—pancreatic cancer	0.000111	0.000407	CcSEcCtD
Zolpidem—Tinnitus—Doxorubicin—pancreatic cancer	0.00011	0.000406	CcSEcCtD
Zolpidem—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.00011	0.000405	CcSEcCtD
Zolpidem—Cardiac disorder—Doxorubicin—pancreatic cancer	0.00011	0.000404	CcSEcCtD
Zolpidem—Flushing—Doxorubicin—pancreatic cancer	0.00011	0.000404	CcSEcCtD
Zolpidem—Flatulence—Epirubicin—pancreatic cancer	0.00011	0.000404	CcSEcCtD
Zolpidem—Tension—Epirubicin—pancreatic cancer	0.000109	0.000402	CcSEcCtD
Zolpidem—Dysgeusia—Epirubicin—pancreatic cancer	0.000109	0.000401	CcSEcCtD
Zolpidem—Nervousness—Epirubicin—pancreatic cancer	0.000108	0.000398	CcSEcCtD
Zolpidem—Back pain—Epirubicin—pancreatic cancer	0.000108	0.000396	CcSEcCtD
Zolpidem—Muscle spasms—Epirubicin—pancreatic cancer	0.000107	0.000394	CcSEcCtD
Zolpidem—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000107	0.000393	CcSEcCtD
Zolpidem—Abdominal pain—Docetaxel—pancreatic cancer	0.000107	0.000392	CcSEcCtD
Zolpidem—Body temperature increased—Docetaxel—pancreatic cancer	0.000107	0.000392	CcSEcCtD
Zolpidem—Chills—Doxorubicin—pancreatic cancer	0.000106	0.000391	CcSEcCtD
Zolpidem—Arrhythmia—Doxorubicin—pancreatic cancer	0.000106	0.000389	CcSEcCtD
Zolpidem—Vision blurred—Epirubicin—pancreatic cancer	0.000105	0.000386	CcSEcCtD
Zolpidem—Mental disorder—Doxorubicin—pancreatic cancer	0.000104	0.000382	CcSEcCtD
Zolpidem—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000103	0.00038	CcSEcCtD
Zolpidem—Malnutrition—Doxorubicin—pancreatic cancer	0.000103	0.000379	CcSEcCtD
Zolpidem—Erythema—Doxorubicin—pancreatic cancer	0.000103	0.000379	CcSEcCtD
Zolpidem—Anaemia—Epirubicin—pancreatic cancer	0.000103	0.000379	CcSEcCtD
Zolpidem—Agitation—Epirubicin—pancreatic cancer	0.000102	0.000377	CcSEcCtD
Zolpidem—Flatulence—Doxorubicin—pancreatic cancer	0.000102	0.000374	CcSEcCtD
Zolpidem—Tension—Doxorubicin—pancreatic cancer	0.000101	0.000372	CcSEcCtD
Zolpidem—Dysgeusia—Doxorubicin—pancreatic cancer	0.000101	0.000371	CcSEcCtD
Zolpidem—Malaise—Epirubicin—pancreatic cancer	0.0001	0.00037	CcSEcCtD
Zolpidem—Nervousness—Doxorubicin—pancreatic cancer	0.0001	0.000368	CcSEcCtD
Zolpidem—Vertigo—Epirubicin—pancreatic cancer	0.0001	0.000368	CcSEcCtD
Zolpidem—Syncope—Epirubicin—pancreatic cancer	9.99e-05	0.000367	CcSEcCtD
Zolpidem—Leukopenia—Epirubicin—pancreatic cancer	9.97e-05	0.000367	CcSEcCtD
Zolpidem—Back pain—Doxorubicin—pancreatic cancer	9.97e-05	0.000367	CcSEcCtD
Zolpidem—Hypersensitivity—Docetaxel—pancreatic cancer	9.93e-05	0.000365	CcSEcCtD
Zolpidem—Muscle spasms—Doxorubicin—pancreatic cancer	9.91e-05	0.000365	CcSEcCtD
Zolpidem—Palpitations—Epirubicin—pancreatic cancer	9.84e-05	0.000362	CcSEcCtD
Zolpidem—Loss of consciousness—Epirubicin—pancreatic cancer	9.79e-05	0.00036	CcSEcCtD
Zolpidem—Cough—Epirubicin—pancreatic cancer	9.72e-05	0.000358	CcSEcCtD
Zolpidem—Vision blurred—Doxorubicin—pancreatic cancer	9.71e-05	0.000357	CcSEcCtD
Zolpidem—Asthenia—Docetaxel—pancreatic cancer	9.67e-05	0.000356	CcSEcCtD
Zolpidem—Hypertension—Epirubicin—pancreatic cancer	9.62e-05	0.000354	CcSEcCtD
Zolpidem—Ill-defined disorder—Doxorubicin—pancreatic cancer	9.56e-05	0.000352	CcSEcCtD
Zolpidem—Pruritus—Docetaxel—pancreatic cancer	9.54e-05	0.000351	CcSEcCtD
Zolpidem—Anaemia—Doxorubicin—pancreatic cancer	9.53e-05	0.00035	CcSEcCtD
Zolpidem—Chest pain—Epirubicin—pancreatic cancer	9.48e-05	0.000349	CcSEcCtD
Zolpidem—Arthralgia—Epirubicin—pancreatic cancer	9.48e-05	0.000349	CcSEcCtD
Zolpidem—Myalgia—Epirubicin—pancreatic cancer	9.48e-05	0.000349	CcSEcCtD
Zolpidem—Agitation—Doxorubicin—pancreatic cancer	9.47e-05	0.000348	CcSEcCtD
Zolpidem—Anxiety—Epirubicin—pancreatic cancer	9.45e-05	0.000348	CcSEcCtD
Zolpidem—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	9.42e-05	0.000346	CcSEcCtD
Zolpidem—Discomfort—Epirubicin—pancreatic cancer	9.37e-05	0.000345	CcSEcCtD
Zolpidem—Malaise—Doxorubicin—pancreatic cancer	9.3e-05	0.000342	CcSEcCtD
Zolpidem—Dry mouth—Epirubicin—pancreatic cancer	9.28e-05	0.000341	CcSEcCtD
Zolpidem—Vertigo—Doxorubicin—pancreatic cancer	9.26e-05	0.000341	CcSEcCtD
Zolpidem—Syncope—Doxorubicin—pancreatic cancer	9.24e-05	0.00034	CcSEcCtD
Zolpidem—Leukopenia—Doxorubicin—pancreatic cancer	9.23e-05	0.000339	CcSEcCtD
Zolpidem—Diarrhoea—Docetaxel—pancreatic cancer	9.22e-05	0.000339	CcSEcCtD
Zolpidem—Confusional state—Epirubicin—pancreatic cancer	9.17e-05	0.000337	CcSEcCtD
Zolpidem—Palpitations—Doxorubicin—pancreatic cancer	9.11e-05	0.000335	CcSEcCtD
Zolpidem—Oedema—Epirubicin—pancreatic cancer	9.09e-05	0.000334	CcSEcCtD
Zolpidem—Anaphylactic shock—Epirubicin—pancreatic cancer	9.09e-05	0.000334	CcSEcCtD
Zolpidem—Loss of consciousness—Doxorubicin—pancreatic cancer	9.06e-05	0.000333	CcSEcCtD
Zolpidem—Infection—Epirubicin—pancreatic cancer	9.03e-05	0.000332	CcSEcCtD
Zolpidem—Cough—Doxorubicin—pancreatic cancer	8.99e-05	0.000331	CcSEcCtD
Zolpidem—Shock—Epirubicin—pancreatic cancer	8.94e-05	0.000329	CcSEcCtD
Zolpidem—Nervous system disorder—Epirubicin—pancreatic cancer	8.92e-05	0.000328	CcSEcCtD
Zolpidem—Dizziness—Docetaxel—pancreatic cancer	8.91e-05	0.000328	CcSEcCtD
Zolpidem—Hypertension—Doxorubicin—pancreatic cancer	8.9e-05	0.000327	CcSEcCtD
Zolpidem—Tachycardia—Epirubicin—pancreatic cancer	8.87e-05	0.000326	CcSEcCtD
Zolpidem—Skin disorder—Epirubicin—pancreatic cancer	8.83e-05	0.000325	CcSEcCtD
Zolpidem—Hyperhidrosis—Epirubicin—pancreatic cancer	8.79e-05	0.000323	CcSEcCtD
Zolpidem—Arthralgia—Doxorubicin—pancreatic cancer	8.78e-05	0.000323	CcSEcCtD
Zolpidem—Chest pain—Doxorubicin—pancreatic cancer	8.78e-05	0.000323	CcSEcCtD
Zolpidem—Myalgia—Doxorubicin—pancreatic cancer	8.78e-05	0.000323	CcSEcCtD
Zolpidem—Anxiety—Doxorubicin—pancreatic cancer	8.74e-05	0.000322	CcSEcCtD
Zolpidem—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	8.71e-05	0.000321	CcSEcCtD
Zolpidem—Discomfort—Doxorubicin—pancreatic cancer	8.67e-05	0.000319	CcSEcCtD
Zolpidem—Anorexia—Epirubicin—pancreatic cancer	8.67e-05	0.000319	CcSEcCtD
Zolpidem—Dry mouth—Doxorubicin—pancreatic cancer	8.58e-05	0.000316	CcSEcCtD
Zolpidem—Vomiting—Docetaxel—pancreatic cancer	8.57e-05	0.000315	CcSEcCtD
Zolpidem—Rash—Docetaxel—pancreatic cancer	8.5e-05	0.000313	CcSEcCtD
Zolpidem—Hypotension—Epirubicin—pancreatic cancer	8.5e-05	0.000312	CcSEcCtD
Zolpidem—Dermatitis—Docetaxel—pancreatic cancer	8.49e-05	0.000312	CcSEcCtD
Zolpidem—Confusional state—Doxorubicin—pancreatic cancer	8.48e-05	0.000312	CcSEcCtD
Zolpidem—Headache—Docetaxel—pancreatic cancer	8.44e-05	0.000311	CcSEcCtD
Zolpidem—Anaphylactic shock—Doxorubicin—pancreatic cancer	8.41e-05	0.000309	CcSEcCtD
Zolpidem—Oedema—Doxorubicin—pancreatic cancer	8.41e-05	0.000309	CcSEcCtD
Zolpidem—Infection—Doxorubicin—pancreatic cancer	8.36e-05	0.000307	CcSEcCtD
Zolpidem—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	8.28e-05	0.000305	CcSEcCtD
Zolpidem—Shock—Doxorubicin—pancreatic cancer	8.28e-05	0.000304	CcSEcCtD
Zolpidem—Nervous system disorder—Doxorubicin—pancreatic cancer	8.25e-05	0.000303	CcSEcCtD
Zolpidem—Insomnia—Epirubicin—pancreatic cancer	8.22e-05	0.000302	CcSEcCtD
Zolpidem—Tachycardia—Doxorubicin—pancreatic cancer	8.21e-05	0.000302	CcSEcCtD
Zolpidem—Skin disorder—Doxorubicin—pancreatic cancer	8.17e-05	0.000301	CcSEcCtD
Zolpidem—Paraesthesia—Epirubicin—pancreatic cancer	8.16e-05	0.0003	CcSEcCtD
Zolpidem—Hyperhidrosis—Doxorubicin—pancreatic cancer	8.13e-05	0.000299	CcSEcCtD
Zolpidem—Dyspnoea—Epirubicin—pancreatic cancer	8.11e-05	0.000298	CcSEcCtD
Zolpidem—Somnolence—Epirubicin—pancreatic cancer	8.08e-05	0.000297	CcSEcCtD
Zolpidem—Anorexia—Doxorubicin—pancreatic cancer	8.02e-05	0.000295	CcSEcCtD
Zolpidem—Nausea—Docetaxel—pancreatic cancer	8.01e-05	0.000294	CcSEcCtD
Zolpidem—Dyspepsia—Epirubicin—pancreatic cancer	8e-05	0.000294	CcSEcCtD
Zolpidem—Decreased appetite—Epirubicin—pancreatic cancer	7.9e-05	0.000291	CcSEcCtD
Zolpidem—Hypotension—Doxorubicin—pancreatic cancer	7.86e-05	0.000289	CcSEcCtD
Zolpidem—Gastrointestinal disorder—Epirubicin—pancreatic cancer	7.85e-05	0.000289	CcSEcCtD
Zolpidem—Fatigue—Epirubicin—pancreatic cancer	7.84e-05	0.000288	CcSEcCtD
Zolpidem—Pain—Epirubicin—pancreatic cancer	7.77e-05	0.000286	CcSEcCtD
Zolpidem—Constipation—Epirubicin—pancreatic cancer	7.77e-05	0.000286	CcSEcCtD
Zolpidem—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	7.66e-05	0.000282	CcSEcCtD
Zolpidem—Insomnia—Doxorubicin—pancreatic cancer	7.61e-05	0.00028	CcSEcCtD
Zolpidem—Paraesthesia—Doxorubicin—pancreatic cancer	7.55e-05	0.000278	CcSEcCtD
Zolpidem—Dyspnoea—Doxorubicin—pancreatic cancer	7.5e-05	0.000276	CcSEcCtD
Zolpidem—Feeling abnormal—Epirubicin—pancreatic cancer	7.49e-05	0.000276	CcSEcCtD
Zolpidem—Somnolence—Doxorubicin—pancreatic cancer	7.48e-05	0.000275	CcSEcCtD
Zolpidem—Gastrointestinal pain—Epirubicin—pancreatic cancer	7.43e-05	0.000273	CcSEcCtD
Zolpidem—Dyspepsia—Doxorubicin—pancreatic cancer	7.4e-05	0.000272	CcSEcCtD
Zolpidem—Decreased appetite—Doxorubicin—pancreatic cancer	7.31e-05	0.000269	CcSEcCtD
Zolpidem—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	7.26e-05	0.000267	CcSEcCtD
Zolpidem—Fatigue—Doxorubicin—pancreatic cancer	7.25e-05	0.000267	CcSEcCtD
Zolpidem—Urticaria—Epirubicin—pancreatic cancer	7.22e-05	0.000266	CcSEcCtD
Zolpidem—Constipation—Doxorubicin—pancreatic cancer	7.19e-05	0.000265	CcSEcCtD
Zolpidem—Pain—Doxorubicin—pancreatic cancer	7.19e-05	0.000265	CcSEcCtD
Zolpidem—Body temperature increased—Epirubicin—pancreatic cancer	7.19e-05	0.000264	CcSEcCtD
Zolpidem—Abdominal pain—Epirubicin—pancreatic cancer	7.19e-05	0.000264	CcSEcCtD
Zolpidem—Feeling abnormal—Doxorubicin—pancreatic cancer	6.93e-05	0.000255	CcSEcCtD
Zolpidem—Gastrointestinal pain—Doxorubicin—pancreatic cancer	6.88e-05	0.000253	CcSEcCtD
Zolpidem—Hypersensitivity—Epirubicin—pancreatic cancer	6.7e-05	0.000246	CcSEcCtD
Zolpidem—Urticaria—Doxorubicin—pancreatic cancer	6.68e-05	0.000246	CcSEcCtD
Zolpidem—Abdominal pain—Doxorubicin—pancreatic cancer	6.65e-05	0.000245	CcSEcCtD
Zolpidem—Body temperature increased—Doxorubicin—pancreatic cancer	6.65e-05	0.000245	CcSEcCtD
Zolpidem—Asthenia—Epirubicin—pancreatic cancer	6.52e-05	0.00024	CcSEcCtD
Zolpidem—Pruritus—Epirubicin—pancreatic cancer	6.43e-05	0.000237	CcSEcCtD
Zolpidem—Diarrhoea—Epirubicin—pancreatic cancer	6.22e-05	0.000229	CcSEcCtD
Zolpidem—Hypersensitivity—Doxorubicin—pancreatic cancer	6.2e-05	0.000228	CcSEcCtD
Zolpidem—Asthenia—Doxorubicin—pancreatic cancer	6.04e-05	0.000222	CcSEcCtD
Zolpidem—Dizziness—Epirubicin—pancreatic cancer	6.01e-05	0.000221	CcSEcCtD
Zolpidem—Pruritus—Doxorubicin—pancreatic cancer	5.95e-05	0.000219	CcSEcCtD
Zolpidem—Vomiting—Epirubicin—pancreatic cancer	5.78e-05	0.000213	CcSEcCtD
Zolpidem—Diarrhoea—Doxorubicin—pancreatic cancer	5.76e-05	0.000212	CcSEcCtD
Zolpidem—Rash—Epirubicin—pancreatic cancer	5.73e-05	0.000211	CcSEcCtD
Zolpidem—Dermatitis—Epirubicin—pancreatic cancer	5.73e-05	0.000211	CcSEcCtD
Zolpidem—Headache—Epirubicin—pancreatic cancer	5.7e-05	0.000209	CcSEcCtD
Zolpidem—Dizziness—Doxorubicin—pancreatic cancer	5.56e-05	0.000205	CcSEcCtD
Zolpidem—Nausea—Epirubicin—pancreatic cancer	5.4e-05	0.000199	CcSEcCtD
Zolpidem—Vomiting—Doxorubicin—pancreatic cancer	5.35e-05	0.000197	CcSEcCtD
Zolpidem—Rash—Doxorubicin—pancreatic cancer	5.3e-05	0.000195	CcSEcCtD
Zolpidem—Dermatitis—Doxorubicin—pancreatic cancer	5.3e-05	0.000195	CcSEcCtD
Zolpidem—Headache—Doxorubicin—pancreatic cancer	5.27e-05	0.000194	CcSEcCtD
Zolpidem—Nausea—Doxorubicin—pancreatic cancer	5e-05	0.000184	CcSEcCtD
